BioCentury | Oct 30, 2006
Company News

Orexo, Doxa deal

...active ingredient is released from a ceramic material. The deal combines ORX's formulation technology and Doxa's...
...ORX will own resulting IP and will have rights to pharmaceutical and medical applications, while Doxa...
...orthopedic and odontologic applications. ORX will make a SEK4 million ($0.5 million) milestone payment to Doxa...
BioCentury | Feb 7, 2005
Company News

Orexo management update

...Business: Drug delivery, Neurology Hired: Nils-Otto Ahnfelt as project director, formerly head of R&D at Doxa AB WIR...
Items per page:
1 - 2 of 2
BioCentury | Oct 30, 2006
Company News

Orexo, Doxa deal

...active ingredient is released from a ceramic material. The deal combines ORX's formulation technology and Doxa's...
...ORX will own resulting IP and will have rights to pharmaceutical and medical applications, while Doxa...
...orthopedic and odontologic applications. ORX will make a SEK4 million ($0.5 million) milestone payment to Doxa...
BioCentury | Feb 7, 2005
Company News

Orexo management update

...Business: Drug delivery, Neurology Hired: Nils-Otto Ahnfelt as project director, formerly head of R&D at Doxa AB WIR...
Items per page:
1 - 2 of 2